CONTACT DETIALS
2175 Visionary Way
Suite 1160
Fishers, IN 46038
(317) 286-6788
ceo@acrobiomedicalco.com
DESCRIPTION
Acro Biomedical is in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. All of the Company’s sales to date have been sales of cordyceps related products and, commencing in the second quarter of the year ended September 30, 2018, metallothionein MT-3 elizer. The Company may also seek to market other products which it sees as complimentary to its present products and conduct research and development on our own proprietary products based on cordyceps sinensis.
| Financial Reporting/Disclosure | |
|---|---|
| Reporting Status | U.S. Reporting: SEC Reporting |
| Audited Financials | Audited |
| Latest Report | Dec 31, 2019 |
| CIK | 0001622996 |
| Fiscal Year End | 12/31 |
| OTC Marketplace | OTCQX |
| Profile Data | |
|---|---|
| SIC – Industry Classification | 7900 – Services-Amusement & Recreation Services |
| Incorporated In: | NV, USA, 2014 |
| Shell: | No |
| Employees | 2 as of 02/05/2020 |
| Company Officers/Contacts | |
|---|---|
| Pao-Chi Chu | President, CEO, CFO |
| Shih-To Li | Advisor |
| Cheng-Hsiang Kao | Consultant |
Company Directors
Pao-Chi Chu
| Service Providers | |
|---|---|
| Accounting/Auditing Firm | Securities Counsel |
| Prager Metis CPAs LLC | Ellenoff Grossman & Schole LLP |
| 15 Warren Street | 1345 Avenue of the Americas |
| Suite 25 | New York, NY 10105 |
| Hackensack, NJ 07601 |
Company Notes
- Formerly=Killer Waves Hawaii, Inc. until 2-2017
ACBM Security Details
| Share Structure | ||
|---|---|---|
| Market Cap | 85,490,400 | 07/10/2020 |
| Authorized Shares | 100,000,000 | 06/30/2020 |
| Outstanding Shares | 47,760,000 | 06/30/2020 |
| -Restricted | 36,100,000 | 06/30/2020 |
| -Unrestricted | 11,660,000 | 06/30/2020 |
| Held at DTC | 575,000 | 06/30/2020 |
| Float | 11,660,000 | 01/24/2019 |
| Par Value | No Par Value |
Transfer Agent(s)
ClearTrust, LLC
| Shareholders | |
|---|---|
| Shareholders of Record 66 | 03/27/2020 |
| Corporate Actions | |||
|---|---|---|---|
| SPLIT DATE | REC DATE | PAY DATE | |
| Dividends & Splits | 05/22/2017 | 05/18/2017 | 05/19/2017 |
| Dividends are not adjusted for stock splits. |
Security Notes
- Capital Change=shs increased by 3 for 1 split. Ex-date=05/22/2017. Rec date=05/18/2017. Pay date=05/19/2017.
| Short Selling Data | |||
|---|---|---|---|
| Short Interest | 26 | (44.44%) | 05/15/2020 |
| Significant Failures to Deliver | No |
